[go: up one dir, main page]

AR058391A1 - USE OF BENZO- FUSIONATED HULEROCICLY DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF PAIN - Google Patents

USE OF BENZO- FUSIONATED HULEROCICLY DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF PAIN

Info

Publication number
AR058391A1
AR058391A1 ARP060105593A AR058391A1 AR 058391 A1 AR058391 A1 AR 058391A1 AR P060105593 A ARP060105593 A AR P060105593A AR 058391 A1 AR058391 A1 AR 058391A1
Authority
AR
Argentina
Prior art keywords
formula
pain
treatment
group
benzo
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of AR058391A1 publication Critical patent/AR058391A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente es un método para el tratamiento del dolor que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente efectiva de uno o más derivados heterocíclicos benzo-fusionados de sulfonamida de formula (1) y formula (2) como se describe aquí. La presente se refiere, además, a métodos para el tratamiento del dolor que comprenden el tratamiento concomitante con agente(s) analgésico(s) y un compuesto de formula (1) o formula (2) como se describe aquí. Reivindicacion 1: Un método para tratar el dolor, que comprende administrar a un sujeto que lo necesita, una cantidad terapéuticamente efectiva de un compuesto de formula (1) donde R1 y R2 se seleccionan, cada uno en forma independiente, del grupo que consiste en H y alquilo inferior; R4 se selecciona del grupo que consiste en H y alquilo inferior; a es un numero entero desde 1 hasta 2; el anillo R se selecciona del grupo que consiste en las formulas (3) a (9) donde b es un numero entero desde 0 hasta 4; y donde c es un numero entero desde 0 hasta 2; cada R5 se selecciona en forma independiente del grupo que consiste en halogeno, alquilo inferior y nitro; siempre que cuando el anillo R es como en formula (8) o (9), entonces a es 1; o una de sus sales aceptables desde el punto de vista farmacéutico. Reivindicacion 6: El método de la reivindicacion 1, en el cual el compuesto de formula (1) se selecciona del grupo que consiste en (2S)-(-)-N-(6-cloro-2,3-dihidro-benzo[1,4]dioxin-2-ilmetil)- sulfamida; y sus sales aceptables desde el punto de vista farmacéutico. Reivindicacion 16: Un método para el tratamiento del dolor, que comprende administrar a un sujeto que lo necesita una cantidad terapéuticamente efectiva de un compuesto de formula (2) o una de sus sales aceptables desde el punto de vista farmacéutico.The present is a method for the treatment of pain which comprises administering to a subject in need thereof a therapeutically effective amount of one or more benzo-fused heterocyclic sulfonamide derivatives of formula (1) and formula (2) as described herein. This also relates to methods for the treatment of pain that include concomitant treatment with analgesic agent (s) and a compound of formula (1) or formula (2) as described herein. Claim 1: A method of treating pain, comprising administering to a subject in need thereof, a therapeutically effective amount of a compound of formula (1) wherein R1 and R2 are each independently selected from the group consisting of H and lower alkyl; R4 is selected from the group consisting of H and lower alkyl; a is an integer from 1 to 2; the ring R is selected from the group consisting of formulas (3) a (9) where b is an integer from 0 to 4; and where c is an integer from 0 to 2; each R5 is independently selected from the group consisting of halogen, lower alkyl and nitro; provided that when the R ring is as in formula (8) or (9), then a is 1; or one of its pharmaceutically acceptable salts. Claim 6: The method of claim 1, wherein the compound of formula (1) is selected from the group consisting of (2S) - (-) - N- (6-chloro-2,3-dihydro-benzo [ 1,4] dioxin-2-ylmethyl) -sulfamide; and its pharmaceutically acceptable salts. Claim 16: A method for the treatment of pain, comprising administering to a subject in need thereof a therapeutically effective amount of a compound of formula (2) or a pharmaceutically acceptable salt thereof.

ARP060105593 2005-12-19 2006-12-18 USE OF BENZO- FUSIONATED HULEROCICLY DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF PAIN AR058391A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75168605P 2005-12-19 2005-12-19
US77381206P 2006-02-15 2006-02-15

Publications (1)

Publication Number Publication Date
AR058391A1 true AR058391A1 (en) 2008-01-30

Family

ID=38813245

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP060105593 AR058391A1 (en) 2005-12-19 2006-12-18 USE OF BENZO- FUSIONATED HULEROCICLY DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF PAIN

Country Status (6)

Country Link
AR (1) AR058391A1 (en)
CL (1) CL2006003588A1 (en)
JO (1) JO2586B1 (en)
PE (1) PE20071066A1 (en)
TW (1) TWI387455B (en)
UY (1) UY30034A1 (en)

Also Published As

Publication number Publication date
TWI387455B (en) 2013-03-01
CL2006003588A1 (en) 2008-02-08
UY30034A1 (en) 2007-03-30
PE20071066A1 (en) 2007-11-19
TW200744580A (en) 2007-12-16
JO2586B1 (en) 2011-02-27

Similar Documents

Publication Publication Date Title
ECSP105253A (en) DERIVATIVES OF 5-PHENYLTIAZOL AND USE AS INHIBITORS OF PI3 CINASA
DK1697371T3 (en) Azabicyclic heterocyclic compounds as cannabinoid receptor modulators
UY29199A1 (en) TIAZOL DERIVATIVES, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCEDURES AND APPLICATIONS
ATE472551T1 (en) TOCOPHEROL MODIFIED THERAPEUTIC DRUG COMPOUND
CR9459A (en) BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME
MX385265B (en) 3-(((((2s,5r)-2-carbamoyl-7-oxo-1,6-diazabicyclo[3.2.1]octan-6-yl)oxy)sulfonyl)oxy)-2,2-dimethylprop noate derivatives and related compounds as perorally administered profrugs of beta-lactamase inhibitors for treating bacterial infections
ECSP066313A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
ECSP066315A (en) DERIVATIVES OF PIRIDAZINE AND ITS USE AS THERAPEUTIC AGENTS
DK1689724T3 (en) Quinazolinone compounds as anticancer agents
DOP2006000252A (en) MUTUAL PROMOTIONS OF GLUCOSAMINE AND GLUCOSAMINE / ANTI-INFLAMMATORY, COMPOSITIONS, AND METHODS
PA8680701A1 (en) OXINDOL DERIVATIVES
AR047928A1 (en) TETRAHYDROPIRIDOINDOL DERIVATIVES
AR058389A1 (en) USE OF SULFAMIDE BENZO-FUSED HETEROCICLIC DERIVATIVES FOR THE TREATMENT OF OBESITY
ECSP045301A (en) USE OF INDOLOPIRROLOCARBAZOL DERIVATIVE AND OTHER ANTI-TARGET AGENTS IN COMBINATION
AR059501A1 (en) USE OF BENZO-HETEROARIL SULFAMIDA DERIVATIVES FOR PAIN TREATMENT
UY28536A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.
AR024998A1 (en) NEW RETINOIDS FOR THE TREATMENT OF THE DISEASE
UY28356A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATIONS OF THE SAME AND ITS USES
AR067454A1 (en) DERIVATIVES OF INDANO-AMINA, ITS PREPARATION AND USE AS MEDICATIONS
EA200602092A1 (en) METHOD AND COMPOSITION FOR THE TREATMENT OF RHINITIS
UY28357A1 (en) DERIVATIVES OF BENZIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION OF THE SAME AND ITS USES
AR058391A1 (en) USE OF BENZO- FUSIONATED HULEROCICLY DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF PAIN
UY28537A1 (en) DERIVATIVES OF BENCIMIDAZOL, COMPOSITIONS THAT CONTAIN THEM, PREPARATION AND USES OF THE SAME.
EA201990766A1 (en) INDOSOLIC COMPOUNDS FOR USE IN DAMAGE OF THE TENDON AND / OR Ligaments
AR058396A1 (en) USE OF SULFAMIDE BENZO-FUSIONATE DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF DEPRESSION

Legal Events

Date Code Title Description
FA Abandonment or withdrawal